Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001078782-13-001068
Filing Date
2013-05-21
Accepted
2013-05-21 17:05:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A f13da052113_sc13dz.htm SC 13D/A 33430
  Complete submission text file 0001078782-13-001068.txt   35170
Mailing Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095
Business Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095 801-446-8802
OphthaliX, Inc. (Subject) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82946 | Film No.: 13862571
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIVA L3 49170
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIVA L3 49170 972 39241114
Can-Fite BioPharma Ltd. (Filed by) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations